Haemonetics (HAE) Tops Q3 EPS by 6c

Haemonetics (NYSE: HAE) reported Q3 EPS of $1.31, $0.06 better than the analyst estimate of $1.25. Revenue for the quarter came in at $338.97 million versus the consensus estimate of $331.91 million.

For earnings history and earnings-related data on Haemonetics (HAE) click here.

You May Also Be Interested In

• BofA sees Micron EPS topping $230 by FY30, calls peak fears overblown
• Btig warns stock investors on seasonal weakness ahead in election year
• NVIDIA (NVDA) call put ratio 1.9 calls to 1 put with a focus on 5K contracts of October 160 puts